OMER Omeros Corp

Omeros Corp is a biopharmaceutical company. It focuses on research and development of small-molecule and protein therapeutics to treat inflammation, coagulopathies, and disorders of the central nervous system and sells Omidria for cataract surgeries.

$3.49  +0.34 (10.79%)
As of 10/03/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/08/2009
Outstanding shares:  62,730,015
Average volume:  590,731
Market cap:   $197,599,547
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B4NB858
Valuation   (See tab for details)
PE ratio:   0.95
PB ratio:   9.18
PS ratio:   -9.38
Return on equity:   -2,232.04%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy